Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cipla
Moodys
Citi
Healthtrust
Federal Trade Commission

Generated: March 20, 2019

DrugPatentWatch Database Preview

Drug Price Trends for MOMETASONE FUROATE

« Back to Dashboard

Drug Price Trends for MOMETASONE FUROATE

Average Pharmacy Cost for MOMETASONE FUROATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
MOMETASONE FUROATE 50 MCG SPRY 65162-0891-29 2.76149 GM 2019-02-20
MOMETASONE FUROATE 0.1% CREAM 00713-0634-37 0.46237 GM 2019-02-20
MOMETASONE FUROATE 0.1% CREAM 00713-0726-15 0.89740 GM 2019-02-20
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for MOMETASONE FUROATE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
NASONEX 50MCG/ACTUATION NASAL SPRAY Merck Sharp & Dohme Corporation 00085-1288-01 17GM 247.19 14.54059 GM 2018-09-01 - 2023-08-31 FSS
ASMANEX HFA 100MCG Merck Sharp & Dohme Corporation 00085-4333-01 1 188.13 188.13000 EACH 2018-09-01 - 2023-08-31 FSS
SINUVA SINUS IMPLANT Intersect ENT, Inc. 10599-0003-01 1 954.39 954.39000 EACH 2018-09-01 - 2023-08-31 Big4
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Teva
Deloitte
Boehringer Ingelheim
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.